The phenomenon of focal segmental glomerulosclerosis post-transplantation - A one-hit wonder?

Pediatric Nephrology

Volumn 27, Issue 12, 2012, Pages 2163-2166

  Saleem, Moin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cytokine; Cytoskeleton; Focal segmental glomerulosclerosis; Plasma factor; Podocyte; Proteinuria; Steroid resistant nephrotic syndrome; TNF

Indexed keywords

ADALIMUMAB; BETA3 INTEGRIN; CARDIOTROPHIN 1; GALACTOSE; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UROKINASE;

CELL ASSAY; DISEASE ACTIVITY; DISEASE MODEL; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR FILTRATION BARRIER; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; KIDNEY TRANSPLANTATION; NONHUMAN; PHENOTYPE; PLASMA FACTOR; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; REVIEW; BLOOD; FEMALE; METABOLISM; NOTE; PATHOLOGY;

FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INTEGRIN BETA3; PODOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879301186     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2218-5     Document Type: Review

References (14)

1. McCarthy HJ, Saleem MA (2011) Genetics in clinical practice: nephrotic and proteinuric syndromes. Nephron Exp Nephrol 118:e1-e8
2. Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366:1648-1649
3. Bitzan M, Babayeva S, Vasudevan A, Goodyer P, Torban E (2012) TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation. Pediatr Nephrol. doi: 10.1007/s00467-012-2163-3
4. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952-960
5. Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M (2008) Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 151:288-292
6. McCarthy ET, Sharma M, Savin VJ (2010) Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5:2115-2121
7. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630-638
8. Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA (2005) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16:629-637
9. Jungraithmayr TC, Hofer K, Cochat P, Chernin G, Cortina G, Fargue S, Grimm P, Knueppel T, Kowarsch A, Neuhaus T, Pagel P, Pfeiffer KP, Schafer F, Schonermarck U, Seeman T, Toenshoff B, Weber S, Winn MP, Zschocke J, Zimmerhackl LB (2011) Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. J Am Soc Nephrol 22:579-585
10. Salmon AH, Satchell SC (2012) Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 226:562-574
11. Haraldsson B, Nystrom J, Deen WM (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88:451-487
12. Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H (2010) Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis 55:50-60
13. Marszal J, Saleem MA (2006) The bioactivity of plasma factors in focal segmental glomerulosclerosis. Nephron Exp Nephrol 104:e1-e5
14. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG (2009) Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77:959-969